No Data
No Data
Neurocrine Biosciences (NBIX) Q1 Earnings Preview: What's in the Cards?
Neurocrine Price Target Cut to $158.00/Share From $163.00 by Canaccord Genuity
Neurocrine Is Maintained at Buy by Canaccord Genuity
Evercore Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Cuts Target Price to $185
New Analyst Forecast: $NBIX Given 'Buy' Rating
Evercore ISI Sticks to Their Buy Rating for Neurocrine (NBIX)